Discover cutting-edge studies on carcinogenesis, biomarkers, and targeted therapeutic approaches
Breakthrough research on triazole-fused pyrimidine derivatives as potent LSD1 inhibitors for epigenetic cancer therapy, particularly in acute myeloid leukemia.